Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_assertion description "[Recent advances in transgenic and gene therapy techniques have presented novel therapeutic strategies for management of heart failure via genetic manipulation of beta-AR signaling including the targeted inhibition of the beta-AR kinase (betaARK1 or GRK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_assertion evidence source_evidence_literature NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_assertion SIO_000772 15524162 NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_assertion wasDerivedFrom befree-2016 NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_assertion wasGeneratedBy ECO_0000203 NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.
- befree-2016 importedOn "2016-02-19" NP467326.RAbNXtQqAycDM65v8aYt819DGe8A0jQpgFJ6pecQherFk130_provenance.